|
Match
|
Document |
Document Title |
|
|
7595327 |
Beta-sulfonamide hydroxamic acid inhibitors of tace/matrix metalloproteinase
This invention provides compounds of Formula I, having the structure:
that are useful in treating diseases or disorders mediated by TNF-α, such as arthritis (rheumatoid arthritis (RA),...
|
|
|
7569602 |
Furan derivatives as EP4 receptor antagonists
A compound of formula (I):
or a salt, solvate and chemically protected form thereof, wherein one of R 2 and R 5 is: (i) H or an optionally substituted C 1-4 alkyl group; or (ii) an...
|
|
|
7534894 |
Biphenyloxy-acids
The present invention relates generally to substituted biphenyloxy acids (such as 4′-aryl-amido-biphenyl-4(3)-yloxy-acids and 4′-aryl-amidomethyl-biphenyl-4(3)-yloxy-acids) and methods of using...
|
|
|
7511073 |
Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
One aspect of the present invention relates to amines. A second aspect of the present invention relates to the use of the amines as inhibitors of a mammalian anandamide transporter. The compounds...
|
|
|
7507817 |
Prostaglandin prodrugs
Novel compounds, and therapeutic methods, compositions and medicament related thereto are disclosed herein.
|
|
|
7468446 |
Substituted heterocyclic compounds and uses thereof
The present invention relates to substituted heterocyclic compounds and compositions comprising a substituted heterocyclic compound. The present invention also relates to methods for preventing or...
|
|
|
7468437 |
Phenyl pyrrolidine ether tachykinin receptor antagonists
The present invention is directed to certain phenyl pyrrolidine ether compounds which are useful as neurokinin-1 (NK-1) receptor antagonists, and inhibitors of tachykinin and in particular...
|
|
|
7442810 |
Method for the production of defined mixtures of THF, BDO and GBL by gas phase hydrogenation
A process for variably preparing mixtures of optionally alkyl-substituted BDO, GBL and THF by two-stage hydrogenation in the gas phase of C 4 dicarboxylic acids and/or derivatives thereof, which...
|
|
|
7432284 |
Estrogen receptor modulators
The present invention relates to compounds and derivatives thereof, their synthesis, and their use as estrogen receptor modulators. The compounds of the instant invention are ligands for estrogen...
|
|
|
7423061 |
Substitute thiophenes and uses thereof
This invention relates to novel compounds having the structural formula (I) and to their pharmaceutical salts, compositions and methods of use. These novel compounds provide a treatment or...
|
|
|
7419943 |
Methanoazuenofurans and methanoazulenone compounds and uses of these compounds as fragrance materials
The use of novel methanoazulenofuran and methanoazulenone compounds for use as fragrance chemicals, suitable for use incorporated in a wide variety of products such as perfumes, colognes and...
|
|
|
7417068 |
EP4 receptor antagonists
A compound of formula (I):
or a salt, solvate and chemically protected form thereof, wherein one of R 2 and R 5 is:
(i) H or an optionally substituted C 1-4 alkyl group; or (ii)an...
|
|
|
7371777 |
Cyclic compound and PPAR agonist
The present invention provides a novel compound having an excellent PPAR agonist action. More specifically, it provides a compound represented by the following formula, a salt thereof, an ester...
|
|
|
7351734 |
Aminoindane derivatives as serotonin and norepinephrine uptake inhibitors
The present invention relates to aminoindane derivatives having the formula I wherein X, Y, U, R 1-2 , R 13-16 and R are as defined in the claims, or an acid addition salt thereof. The compounds...
|
|
|
7351311 |
Method for purifying tetrahydrofuran by distillation
Crude water-containing tetrahydrofuran is purified by passing the crude tetrahydrofuran through three distillation columns, withdrawing water from the bottom of the first column, recycling...
|
|
|
7345181 |
Process for preparing prostaglandin derivatives and starting materials for the same
The present invention provides a process for preparing benzoprostacycline derivatives of formula (1), i.e. 5,6,7-trinor-4,8-inter-m-phenylene PGI2 derivatives, and vinyl tin compounds of formula...
|
|
|
7329634 |
3-Phenyl substituted 3-substituted-4ketolactams and ketolactones
The invention relates to novel 3-phenyl-substituted, 3-substituted 4-ketolactams and -lactones of the formula (I)
in which Q, W, X, Y, A, B and G are as defined in the disclosure, to...
|
|
|
7316851 |
Electroluminescent material, electroluminescent element and color conversion filter
An electroluminescent element is disclosed, comprising an electroluminescent material and a fluorescent substance emitting light having an emission maximum at the wavelength different from that of...
|
|
|
7276573 |
Method for producing monoesters and diesters of polytetrahydrofuran and of tetrahydrofuran copolymers
The present invention provides a process for preparing mono- or diesters of polytetrahydrofuran or of tetrahydrofuran copolymers by polymerizing tetrahydrofuran in the presence of at least one...
|
|
|
RE39794 |
Process for the simultaneous production of maleic anhydride and its hydrogenated derivatives
A process is described for the co-production of maleic anhydride and at least one C 4 compound selected from butane-1,4-diol, γ-butyrolactone, and tetrahydrofuran in which maleic anhydride is...
|
|
|
7256203 |
Dicationic 2,5-diarylfuran aza-analogs as anti-protozoan agents
A compound of Formula (I):
wherein:
X is selected from the group consisting of O, S, and NR 17 , where R 17 is hydrogen or lower alkyl; A and Y are CH, N, NR 17 , O, or S; C 1 and C 2 ...
|
|
|
7148318 |
Method for producing polytetrahydrofurane having a low color indices
The invention provides a process for preparing polytetrahydrofuran, tetrahydrofuran copolymers, their monoesters or diesters and the monoesters or diesters of polytetrahydrofuran having a low color...
|
|
|
7144909 |
Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands
This invention relates to novel compounds which are thyroid receptor ligands, preferably antagonists, and to methods for using such compounds in the treatment of cardiac and metabolic disorders,...
|
|
|
7122561 |
Treatment of skin conditions
The present invention provides piperine and analogues or derivatives thereof for the treatment of skin conditions treatable by stimulation of melanocyte proliferation, such as vitiligo, and also...
|
|
|
7109343 |
Metal catalysts and methods for making and using same
Compounds having the formula:
are disclosed. M 1 and M 2 are the same or different and are transition metal atoms or ions; Z 2 and Z 3 , independently, are the atoms necessary to complete a...
|
|
|
7105707 |
Process for preparing alkynyl-substituted aromatic and heterocyclic compounds
Mono- and disubstituted aryl or heterocyclic acetylenes are produced by a process comprising reacting an aryl nitrile with an alkynylzinc compound, a bis-alkynylzinc compound, or an...
|
|
|
7091344 |
Infrared chromophores
An infrared dye, characterized in that the dye comprises of Formulae 1 to 5
|
|
|
7081467 |
C2-disubstituted indan-1-ones and their derivatives, processes for their preparation and their use as pharmaceuticals
The present invention is directed C2-disubstituted indan-1-ones of the Formula I,
physiologically acceptable salts, and physiologically functional derivatives thereof, and pharmaceutical...
|
|
|
7074944 |
Method for producing polytetrahydrofuran
In a process for the single-stage preparation of polytetrahydrofuran and/or tetrahydrofuran copolymers having a mean molecular weight of from 650 to 5000 dalton by polymerization of tetrahydrofuran...
|
|
|
7064222 |
Processes for the preparation of 2-methylfuran and 2-methyltetrahydrofuran
Processes are disclosed for the preparation of 2-methylfuran and 2-methyltetrahydrofuran. The continuous vapor-phase processes are commercially viable and efficient because they permit the...
|
|
|
7057055 |
Process for preparing a deuterated or tritiated compound
A process for labeling organic compounds with deuterium and tritium is described using specific catalysts.
|
|
|
7049329 |
Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
One aspect of the present invention relates to amines. A second aspect of the present invention relates to the use of the amines as inhibitors of a mammalian anandamide transporter. The compounds...
|
|
|
6930188 |
Stable hydrate of a muscarinic receptor antagonist
A stable solid hydrate of a muscarinic receptor antagonist is useful in the treatment of irritable bowel syndrome, diverticular disease, oesophageal achalasia, chronic obstructive airways disease,...
|
|
|
6921831 |
Modified BiMo catalyst and process for use thereof
Modified lead/bismuth/molybdate catalysts containing vanadium, copper, or gold have been prepared, and are selective to the corresponding furan compound from the gas phase oxidation of an...
|
|
|
6906196 |
Processes for the preparation of 1,5-diaryl-3-substituted-pyrazoles
Provided are processes and chemical intermediates useful for preparing a compound of the formula I
wherein X is selected from the group consisting of C 1 -C 6 trihalomethyl; C 1 -C 6 ...
|
|
|
6903132 |
Non-peptide GnRH agents, pharmaceutical compositions and methods for their use
Non-peptide GnRH agents capable of inhibiting the effect of gonadotropin-releasing hormone are described. Such compounds and their pharmaceutically acceptable salts, prodrugs, and active...
|
|
|
6894039 |
Selenophene anti-tumor agents
Novel selenophene compounds useful as anti-tumor agents are described. Preferred compounds include compounds of formula I:
wherein R 1 and R 2 are independently selected from the group...
|
|
|
6875784 |
Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives
The present invention provides certain [3.1.0] bicyclic oxazolidinone derivatives of Formulea I and II, described herein, or pharmaceutically acceptable salts or prodrugs thereof that are...
|
|
|
6864225 |
Cyclic ketals, fragrance compositions containing the same and methods of using the same
Compounds of the general formula (I) are described:
wherein each of R 1 , R 2 , R 3 , R 4 , R 5 and R 6 independently represents a substituent selected from the group consisting of hydrogen,...
|
|
|
6844375 |
4-methylene-1,3-dioxolanes as cross-linking agents
The invention relates to: 4-methylene-1,3-dioxolanes of the general formula (I)
wherein R1 denotes hydrogen, C 5 -C 6 -cycloalkyl or C 1 -C 4 -alkyl; m and n, which may be the same or...
|
|
|
6812354 |
Process for preparing 3-methyltetrahydrofuran
Disclosed is a process for the preparation of 3-methyltetrahydrofuran (MeTHF) from 3-(hydroxymethyl)tetrahydrofuran (HOMeTHF) or 3-formyltetrahydrofuran (FTHF) by contacting HOMeTHF or...
|
|
|
6764829 |
Nucleoside hydrolase and nucleoside phosphorylase detection kits, dipsticks and substrates
The invention relates to a method of detecting and/or assaying nucleoside hydrolases or nucleoside phosphorylases using a chromogenic substrate. Preferred chromogenic substrates have formula (I)...
|
|
|
6762304 |
Metal catalysts and methods for making and using same
Compounds having the formula: are disclosed. M 1 and M 2 are the same or different and are transition metal atoms or ions; Z 2 and Z 3 , independently, are the atoms necessary to complete a...
|
|
|
6762198 |
Dihetero-substituted metalloprotease inhibitors
Disclosed are compounds which are inhibitors of metalloproteases and which are effective in treating conditions characterized by excess activity of these enzymes. In particular, the compounds have...
|
|
|
6730800 |
Method for the production of tetrahydrofuran
Unsubstituted or alkyl-substituted THF is obtained by catalytic hydrogenation in the gas phase of C 4 -dicarboxylic acids and/or their derivatives using a catalyst comprising <80% by weight,...
|
|
|
6716987 |
Derivatives of benzofuran or benzodioxazole compounds
An oxygen-containing heterocyclic compound represented by following Formula (I): wherein R 1 and R 2 independently represent hydrogen, lower alkyl, cyano, —(CH 2 ) n —E 1 —CO—G 1 ...
|
|
|
6683211 |
Phenyl-propargylether derivatives
The invention relates to phenyl-propargylether derivatives of the general formula I including the optical isomers thereof and mixtures of such isomers, wherein R 1 is hydrogen, alkyl,...
|
|
|
6683107 |
Furans, benzofurans, and thiophenes useful in the treatment of insulin resistance and hyperglycemia
This invention provides compounds of Formula I having the structure wherein R 1 and R 2 are each, independently, hydrogen, alkyl of 1-6 carbon atoms, halogen, perfluoroalkyl of 1-6 carbon...
|
|
|
6680391 |
Treatment of skin conditions
The present invention provides piperine and analogues or derivatives thereof for the treatment of skin conditions treatable by stimulation of melanocyte proliferation, such as vitiligo, and also...
|
|
|
6660728 |
Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists
The present invention relates to thienyl substituted acylguanidine derivatives, such as compounds of formula (I) in which R 1 , R 2 , R 4 , R 6 , A, B and D have the meanings indicated in the...
|